RWDD2B inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the RWDD2B protein, a relatively understudied but important protein involved in regulating cellular processes. RWDD2B, a member of the RWDD family of proteins, is known for containing the RWD domain, which is associated with protein-protein interactions. This domain is involved in diverse biological functions, including signal transduction, ubiquitination, and cellular homeostasis. Inhibiting RWDD2B can disrupt its participation in these processes, making it a useful target for studying its role in intracellular signaling and protein modification pathways. By blocking RWDD2B activity, researchers can investigate its influence on cellular functions such as protein stability, degradation, and regulatory complexes.
The mechanisms of RWDD2B inhibitors can vary depending on how they interact with the protein. Some inhibitors may directly bind to the RWD domain, preventing RWDD2B from forming functional complexes with other proteins. Others may alter its conformation, inhibiting its ability to interact with signaling molecules or participate in ubiquitin-related processes. These inhibitors are valuable for probing the molecular mechanisms behind RWDD2B's role in cellular pathways and for dissecting the broader regulatory networks in which it is involved. By inhibiting RWDD2B, researchers can gain insights into the protein's specific contributions to maintaining cellular homeostasis, the modulation of protein-protein interactions, and the regulation of ubiquitination processes. This understanding aids in deciphering the intricate roles that RWDD2B plays in various biological systems.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Through its action as a DNA methyltransferase inhibitor, 5-Azacytidine may cause hypomethylation of the RWDD2B gene promoter, leading to its transcriptional downregulation. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid may lead to hyperacetylation of histones at the RWDD2B gene locus, causing transcriptional repression due to chromatin structure alterations. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
If the RWDD2B gene contains retinoic acid response elements, the binding of retinoic acid may suppress the gene's transcriptional activity through receptor-mediated recruitment of co-repressors. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
By binding to specific DNA sequences, Mithramycin A could competitively inhibit transcription factor binding at the RWDD2B promoter, leading to decreased mRNA synthesis. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin may downregulate the expression of RWDD2B by altering the activity of specific transcription factors or by changing the methylation status of its promoter region. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
This compound may exert its effect by reducing the transcriptional activity of signal transduction pathways that promote the expression of the RWDD2B gene. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
This compound could downregulate RWDD2B expression by altering the methylation and acetylation state of histones associated with the RWDD2B gene, thereby altering gene accessibility. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate may cause the hyperacetylation of histone proteins at the RWDD2B promoter, resulting in transcriptional repression and decreased gene expression. | ||||||
PI-103 | 371935-74-9 | sc-203193 sc-203193A | 1 mg 5 mg | $33.00 $131.00 | 3 | |
By inhibiting PI3K/mTOR pathways, PI-103 could lead to a reduction in the transcript and protein levels of factors that are necessary for RWDD2B gene transcription. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 may inhibit the transcription of RWDD2B by reducing the activity of the PI3K/Akt pathway, which can be critical for the expression of certain genes. | ||||||